Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial

BACKGROUND: Trastuzumab has been approved for patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic gastric carcinoma; however, relatively little is known about the role of HER2 in the natural history of this disease. PATIENTS AND METHODS: Patients enrolled in the INT-011...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Gordon, M. A., Gundacker, H. M., Benedetti, J., Macdonald, J. S., Baranda, J. C., Levin, W. J., Blanke, C. D., Elatre, W., Weng, P., Zhou, J. Y., Lenz, H. J., Press, M. F.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2013
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3690906/
https://ncbi.nlm.nih.gov/pubmed/23524864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdt106
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia